Atreca (BCEL)
(Delayed Data from OTC)
$0.09 USD
0.00 (-2.07%)
Updated May 21, 2024 09:30 AM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Income Statements
Fiscal Year end for Atreca, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 0 | 0 | 0 | 0 |
Cost Of Goods | NA | 0 | 0 | 0 | 0 |
Gross Profit | NA | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 98 | 110 | 89 | 73 |
Income After Depreciation & Amortization | 0 | -98 | -110 | -89 | -73 |
Non-Operating Income | NA | 1 | 1 | 3 | 5 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | -97 | -109 | -86 | -67 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -97 | -109 | -86 | -67 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -97 | -109 | -86 | -67 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -91 | -106 | -87 | -71 |
Depreciation & Amortization (Cash Flow) | NA | 7 | 5 | 2 | 2 |
Income After Depreciation & Amortization | 0 | -98 | -110 | -89 | -73 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 38.59 | 37.04 | 31.93 | 15.83 |
Diluted EPS Before Non-Recurring Items | NA | -2.52 | -2.95 | -2.70 | -4.26 |
Diluted Net EPS (GAAP) | NA | -2.52 | -2.95 | -2.70 | -4.26 |
Fiscal Year end for Atreca, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | NA | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | NA | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 36.65 | 19.76 | 21.53 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -36.65 | -19.76 | -21.53 |
Non-Operating Income | NA | NA | 0.43 | 0.56 | 0.52 |
Interest Expense | NA | NA | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | NA | -36.22 | -19.19 | -21.01 |
Income Taxes | NA | NA | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | -36.22 | -19.19 | -21.01 |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | -36.22 | -19.19 | -21.01 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 39.36 | 39.16 | 39.09 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.39 | -0.49 | -0.54 |
Diluted Net EPS (GAAP) | NA | NA | -0.92 | -0.49 | -0.54 |